Retour
Fourchette du Jour
10,74 €
11,27 €
Fourchette 52 Semaines
3,90 €
14,93 €
Volume
855 221
Moyenne 50J / 200J
11,52 €
/
10,97 €
Clôture Précédente
11,13 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -8,6 | 0,3 |
| P/B | 2,9 | 2,9 |
| ROE % | -41,3 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
21,75 €
+95.9%
Low: 15,00 €
High: 25,00 €
BPA Prévisionnel
-1,40 €
CA Est.
8,2 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-0,37 €
-0,37 € – -0,37 €
|
260 M | 2 |
| FY2029 |
-1,72 €
-1,72 € – -1,72 €
|
73 M | 4 |
| FY2028 |
-1,64 €
-1,99 € – -1,19 €
|
11 M | 6 |
Points Clés
Debt/Equity of 0,03 — conservative balance sheet
Negative free cash flow of -114,08M
PEG of 0,28 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-41,27%
ROIC-27,09%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,03
Current Ratio14,13
Interest Coverage0,00
Valorisation
P/E Ratio
-8,60
P/B Ratio2,90
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -129,47M |
| ROE | -41,27% | ROA | -31,50% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -114,08M |
| ROIC | -27,09% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,03 | Current Ratio | 14,13 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -8,60 | P/B Ratio | 2,90 |
| P/S Ratio | N/A | PEG Ratio | 0,28 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,11B | Enterprise Value | 1,08B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -129,47M | -127,85M | -100,70M | -89,12M | -78,72M |
| EPS (Diluted) | -1,47 | -1,83 | -1,96 | -2,25 | -2,07 |
| Gross Profit | -1,22M | -1,11M | -1,03M | 0,0 | 0,0 |
| Operating Income | -143,00M | -142,90M | -110,78M | -91,77M | -78,87M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 411,00M | 274,14M | 254,69M | 250,36M | 298,64M |
| Total Liabilities | 26,64M | 31,02M | 30,60M | 28,01M | 25,67M |
| Shareholders' Equity | 384,36M | 243,12M | 224,09M | 222,35M | 272,98M |
| Total Debt | 11,55M | 3,18M | 10,21M | 12,10M | 1,93M |
| Cash & Equivalents | 45,67M | 59,41M | 23,38M | 66,84M | 226,01M |
| Current Assets | 288,47M | 262,25M | 212,60M | 210,46M | 240,52M |
| Current Liabilities | 20,42M | 24,85M | 20,46M | 15,39M | 15,15M |